Logo image of DCBO

DOCEBO INC (DCBO) Stock Fundamental Analysis

USA - NASDAQ:DCBO - CA25609L1058 - Common Stock

29.86 USD
-0.76 (-2.48%)
Last: 9/16/2025, 8:10:28 PM
29.86 USD
0 (0%)
After Hours: 9/16/2025, 8:10:28 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to DCBO. DCBO was compared to 280 industry peers in the Software industry. While DCBO has a great health rating, its profitability is only average at the moment. DCBO is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, DCBO could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DCBO was profitable.
DCBO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
DCBO had a positive operating cash flow in 4 of the past 5 years.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

DCBO has a Return On Assets of 12.51%. This is amongst the best in the industry. DCBO outperforms 89.64% of its industry peers.
DCBO's Return On Equity of 61.75% is amongst the best of the industry. DCBO outperforms 96.79% of its industry peers.
DCBO's Return On Invested Capital of 32.53% is amongst the best of the industry. DCBO outperforms 97.14% of its industry peers.
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROIC 32.53%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

DCBO's Profit Margin of 9.29% is fine compared to the rest of the industry. DCBO outperforms 72.86% of its industry peers.
With a decent Operating Margin value of 9.67%, DCBO is doing good in the industry, outperforming 74.64% of the companies in the same industry.
DCBO has a better Gross Margin (81.00%) than 83.21% of its industry peers.
DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.67%
PM (TTM) 9.29%
GM 81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

7

2. Health

2.1 Basic Checks

DCBO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, DCBO has about the same amount of shares outstanding.
Compared to 5 years ago, DCBO has more shares outstanding
DCBO has a better debt/assets ratio than last year.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.78 indicates that DCBO is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.78, DCBO is doing good in the industry, outperforming 63.57% of the companies in the same industry.
DCBO has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
DCBO has a better Debt to FCF ratio (0.05) than 82.14% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that DCBO is not too dependend on debt financing.
DCBO has a Debt to Equity ratio of 0.01. This is in the better half of the industry: DCBO outperforms 63.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Altman-Z 3.78
ROIC/WACC3.12
WACC10.42%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.04 indicates that DCBO should not have too much problems paying its short term obligations.
DCBO has a Current ratio of 1.04. This is in the lower half of the industry: DCBO underperforms 70.71% of its industry peers.
DCBO has a Quick Ratio of 1.04. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DCBO (1.04) is worse than 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.70% over the past year.
Looking at the last year, DCBO shows a quite strong growth in Revenue. The Revenue has grown by 15.11% in the last year.
Measured over the past years, DCBO shows a very strong growth in Revenue. The Revenue has been growing by 39.25% on average per year.
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%

3.2 Future

DCBO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.76% yearly.
DCBO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.94% yearly.
EPS Next Y35.45%
EPS Next 2Y32.13%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.15, which means the current valuation is very expensive for DCBO.
Based on the Price/Earnings ratio, DCBO is valued a bit cheaper than 68.21% of the companies in the same industry.
DCBO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
DCBO is valuated rather expensively with a Price/Forward Earnings ratio of 19.89.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 75.71% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.71. DCBO is around the same levels.
Industry RankSector Rank
PE 27.15
Fwd PE 19.89
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

DCBO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 73.93% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DCBO is valued a bit cheaper than 70.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.88
EV/EBITDA 30.96
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DCBO may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 34.47% in the coming years.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y32.13%
EPS Next 3Y34.47%

0

5. Dividend

5.1 Amount

DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

NASDAQ:DCBO (9/16/2025, 8:10:28 PM)

After market: 29.86 0 (0%)

29.86

-0.76 (-2.48%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners36.86%
Inst Owner Change-8.77%
Ins Owners1.46%
Ins Owner ChangeN/A
Market Cap857.88M
Analysts78.67
Price Target29.97 (0.37%)
Short Float %2.68%
Short Ratio4.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.06%
Min EPS beat(2)26.05%
Max EPS beat(2)28.07%
EPS beat(4)3
Avg EPS beat(4)41.65%
Min EPS beat(4)-25.3%
Max EPS beat(4)137.79%
EPS beat(8)7
Avg EPS beat(8)31.82%
EPS beat(12)10
Avg EPS beat(12)131.11%
EPS beat(16)13
Avg EPS beat(16)110.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.44%
Revenue beat(12)2
Avg Revenue beat(12)-0.71%
Revenue beat(16)3
Avg Revenue beat(16)-0.87%
PT rev (1m)2.22%
PT rev (3m)1.22%
EPS NQ rev (1m)9.81%
EPS NQ rev (3m)6.52%
EPS NY rev (1m)-2.91%
EPS NY rev (3m)-2.91%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)-3.05%
Revenue NY rev (1m)1.25%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 27.15
Fwd PE 19.89
P/S 3.72
P/FCF 31.88
P/OCF 30.37
P/B 24.73
P/tB 45.63
EV/EBITDA 30.96
EPS(TTM)1.1
EY3.68%
EPS(NY)1.5
Fwd EY5.03%
FCF(TTM)0.94
FCFY3.14%
OCF(TTM)0.98
OCFY3.29%
SpS8.02
BVpS1.21
TBVpS0.65
PEG (NY)0.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 61.75%
ROCE 55.51%
ROIC 32.53%
ROICexc N/A
ROICexgc N/A
OM 9.67%
PM (TTM) 9.29%
GM 81%
FCFM 11.67%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 39.68%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 110.06%
Profit Quality 125.62%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 3.78
F-Score8
WACC10.42%
ROIC/WACC3.12
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.33%
EPS Next Y35.45%
EPS Next 2Y32.13%
EPS Next 3Y34.47%
EPS Next 5Y27.76%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%14.47%
Revenue Next Year11.22%
Revenue Next 2Y9.78%
Revenue Next 3Y9.84%
Revenue Next 5Y24.94%
EBIT growth 1Y84.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.45%
EBIT Next 3Y50.2%
EBIT Next 5Y32.58%
FCF growth 1Y380.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y338.61%
OCF growth 3YN/A
OCF growth 5YN/A